Education
About Us
Working with TipRanks
Follow Us
Rapid Micro Biosystems (RPID)
NASDAQ:RPID
RPID Stock Chart & Stats
$2.93
-$0.03(-2.88%)
At close: 4:00 PM EST
$2.93
-$0.03(-2.88%)
Day’s Range― - ―
52-Week Range$0.87 - $4.50
Previous CloseN/A
Volume19.55K
Average Volume (3M)83.17K
Market Cap
$138.82M
Enterprise Value$128.36M
Total Cash (Recent Filing)$31.25M
Total Debt (Recent Filing)$5.58M
Price to Earnings (P/E)―
Beta0.96
Next Earnings
Nov 06, 2025EPS Estimate
-0.25Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.27
Shares Outstanding39,710,800
10 Day Avg. Volume90,537
30 Day Avg. Volume83,166
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue4.24
Enterprise Value/Gross Profit22.41
Enterprise Value/Ebitda-2.92
Forecast
1Y Price Target
$6.33Price Target Upside116.04% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
Bulls Say, Bears Say
Bulls Say
Automation In BiopharmaA strong shift towards automation among biopharma customers is expected, with Growth Direct systems providing significant cost savings by replacing 2-3 full-time employees.
Growth DriversManagement noted key FY26 growth drivers including a strong sales funnel featuring multiple multi-system rollouts, MilliporeSigma having purchase commitments beginning in FY26, durable consumables and service growth as the installed base grows, and a strong competitive positioning to benefit from the US onshoring of biopharma manufacturing.
Market LeadershipRapid Micro Biosystems is emerging as the category leader in microbial quality control automation with its Growth Direct platform, a system that compresses testing timelines from weeks to days, reduces contamination risk, and ensures compliance with increasingly strict regulatory requirements.
Bears Say
Spending UncertaintySpending uncertainty and tariff impact are driving expectations toward the lower end of 21-25 placements.
Rapid Micro Biosystems News
RPID FAQ
What was Rapid Micro Biosystems’s price range in the past 12 months?
Rapid Micro Biosystems lowest stock price was $0.87 and its highest was $4.50 in the past 12 months.
What is Rapid Micro Biosystems’s market cap?
Rapid Micro Biosystems’s market cap is $138.82M.
When is Rapid Micro Biosystems’s upcoming earnings report date?
Rapid Micro Biosystems’s upcoming earnings report date is Nov 06, 2025 which is in 15 days.
How were Rapid Micro Biosystems’s earnings last quarter?
Rapid Micro Biosystems released its earnings results on Aug 12, 2025. The company reported -$0.27 earnings per share for the quarter, missing the consensus estimate of -$0.253 by -$0.017.
Is Rapid Micro Biosystems overvalued?
According to Wall Street analysts Rapid Micro Biosystems’s price is currently Undervalued.
Does Rapid Micro Biosystems pay dividends?
Rapid Micro Biosystems does not currently pay dividends.
What is Rapid Micro Biosystems’s EPS estimate?
Rapid Micro Biosystems’s EPS estimate is -0.25.
How many shares outstanding does Rapid Micro Biosystems have?
Rapid Micro Biosystems has 39,710,800 shares outstanding.
What happened to Rapid Micro Biosystems’s price movement after its last earnings report?
Rapid Micro Biosystems reported an EPS of -$0.27 in its last earnings report, missing expectations of -$0.253. Following the earnings report the stock price went down -17.791%.
Which hedge fund is a major shareholder of Rapid Micro Biosystems?
Currently, no hedge funds are holding shares in RPID
Rapid Micro Biosystems Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$6.33 (116.04% Upside)
$6.33 (116.04% Upside)
Blogger Sentiment
Bullish
RPID Sentiment 100%
Sector Average ―
Sector Average ―
Crowd Wisdom
Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▼ 0.9%
Last 30 Days ▼ 0.9%
Technicals
SMA
Positive
20 days / 200 days
Momentum
238.72%
12-Months-Change
Fundamentals
Return on Equity
-59.15%
Trailing 12-Months
Asset Growth
-35.44%
Trailing 12-Months
Company Description
Rapid Micro Biosystems
Rapid Micro Biosystems (RPID) is a biotechnology company focused on advancing microbial quality control solutions for the pharmaceutical, biotechnology, and personal care industries. The company specializes in innovative technologies that streamline microbial testing processes, primarily through its Growth Direct System, which allows for rapid and automated detection of microbial contamination in products and environments. RPID aims to enhance quality assurance processes, reduce time to market, and improve product safety for its clients.
RPID Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted significant revenue growth and strategic advancements, including a new loan facility and partnership progress. However, challenges remain with product margins and ongoing market uncertainties affecting system placements.View all RPID earnings summariesRPID Stock 12 Month Forecast
Average Price Target
$6.33
▲(116.04% Upside)
Technical Analysis
Ownership Overview
5.08% Insiders
2.72% Mutual Funds
30.38% Other Institutional Investors
59.45% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---